Adverum Biotechnologies Inc Share Price

NASDAQ: ADVM

Small Cap

$3.06

+0.04

(+1.32%)

as on September 16, 2025 at 1:29 am IST

$₹

Adverum Biotechnologies Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$3.04
Day's Price Range
$3.23
$3.06
0.65%
Downside
5.56%
Upside
52 Week's Low
52 Week's High
$1.78
52-Week Price Range
$8.56
$3.06
41.83%
Downside
179.74%
Upside

Adverum Biotechnologies Inc share price movements today

Previous Close: $3.02
Open: $3.14
Volume: 254.2K
Day's Low - High: $3.04 - $3.23
52 Week Low - High: $1.78 - $8.56

Adverum Biotechnologies Inc Historical Returns

1 Month Return: + 5.59 %
3 Month Return: + 22.76 %
1 Year Return: -58.23 %
3 Year Return: -72.55 %
5 Year Return: -97.65 %

Adverum Biotechnologies Inc Stock Fundamentals & Key Indicators

Check Adverum Biotechnologies Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$63.4M

EPS (TTM)

-5.31

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-172.2M

Revenue (TTM)

1.0M

Profit Margin

0.00%

Return On Equity TTM

1527100.00%

Adverum Biotechnologies Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adverum Biotechnologies Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Adverum Biotechnologies Inc	BUY	$63.4M	-97.65%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Adverum Biotechnologies Inc Stock including INR - Dollar returns

The Adverum Biotechnologies Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Adverum Biotechnologies Inc investment value today

Current value as on today

₹47,309

Returns

₹52,691

(-52.69%)

Returns from Adverum Biotechnologies Inc Stock

₹57,676 (-57.68%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Adverum Biotechnologies Inc Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Adverum Biotechnologies Inc. Average target price of $19.5

Adverum Biotechnologies Inc Share Price Target

Get share price movements and forecasts by analysts on Adverum Biotechnologies Inc.

What analysts predicted

84.31%UPSIDE

Target Price

$19.5

Current Price

$3.06

Analyzed by

13 Analysts

Target

$19.50

Adverum Biotechnologies Inc target price $19.5, a slight upside of 84.31% compared to current price of $3.06. According to 13 analysts rating.

Adverum Biotechnologies Inc Stock's Interest Amongst Investors

Search interest for Adverum Biotechnologies Inc Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-44% versus previous 30 day period

Adverum Biotechnologies Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	3	-	-	-3	-	-	1	-	-3	-
Gross Profit	3	-7	-1	-4	0	0	0	-	0	0
Operating Income	-30	-33	-34	-31	-28	-32	-30	-62	-48	-49
EBITDA	-28	-24	-33	-24	-26	-29	-26	-	-46	-48
Interest Expense	1	-	-	1	-	-	-	-	-	-
Depreciation	1	1	1	1	0	0	0	0	0	0
Income Before Tax	-29	-31	-32	-29	-24	-30	-27	-60	-47	-49
Income Tax Expense	0	0	0	-1	0	-	2	-	0	-
Net Income	-29	-31	-32	-23	-24	-18	-27	-60	-47	-49
Net Profit Margin	-807.11%	0.00%	0.00%	658.72%	0.00%	0.00%	-2713.40%	0.00%	1306.08%	0.00%

Adverum Biotechnologies Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	2	1	1	1	0	7	7	3	3	1
Gross Profit	2	1	0	1	0	-4	2	-6	-2	-2
Operating Income	-47	-115	-58	-78	-68	-117	-145	-155	-128	-153
EBITDA	-46	-52	-54	-72	-62	-112	-140	-147	-117	-127
Interest Expense	-	-	-	-	-	1	0	2	-	-
Depreciation	-	-	2	1	1	4	4	6	5	3
Income Before Tax	-47	-114	-56	-73	-64	-116	-145	-154	-123	-130
Income Tax Expense	1	0	-10	-1	1	1	4	0	-1	-
Net Income	-47	-113	-56	-72	-64	-117	-145	-154	-122	-130
Net Profit Margin	-2046.27%	-7817.66%	-3036.61%	-4505.40%	-25794.40%	-1566.76%	-1940.53%	-4292.67%	-3392.11%	-13092.70%

Adverum Biotechnologies Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-31	-32	-23	-24	-18	-27	-40	-47	-49
Operating Cash Flow	-23	-23	-21	-23	-19	-21	-28	-42	-38
Investing Cash Flow	67	18	-9	-22	-2	-13	-	31	31
Financing Cash Flow	0	0	0	119	0	-	0	0	0
Change in Cash	43	-5	-30	74	-22	-34	-32	-11	-6

Adverum Biotechnologies Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-113	-56	-72	-64	-117	-145	-154	-122	-130
Operating Cash Flow	-38	-45	-53	-49	-79	-107	-108	-90	-92
Investing Cash Flow	38	-122	69	-68	-280	78	141	96	-41
Financing Cash Flow	0	16	69	28	355	2	0	0	120
Change in Cash	0	-151	85	-89	-3	-26	34	6	-14

Global Institutional Holdings in Adverum Biotechnologies Inc

Funds	Holdings
BML Capital Management LLC	13.13%
TCG Crossover Management, LLC	8.6%
Franklin Resources Inc	8.43%
BlackRock Inc	6.83%
Vanguard Group Inc	4.93%

See all

Insights on Adverum Biotechnologies Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 196.0%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 133.8%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ADVM stock has moved down by -14.7%

About Adverum Biotechnologies Inc

adverum (nasdaq: advm) is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. we are advancing the development of a robust pipeline of gene therapies that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (a1at) deficiency and hereditary angioedema (hae) as well as wet age-related macular degeneration (wamd). leveraging our next-generation adeno-associated virus (aav)-based directed evolution platform, we generate gene therapies designed to provide durable efficacy by inducing sustained expression of a therapeutic protein.

Organisation	Adverum Biotechnologies Inc
Headquarters	100 Cardinal Way, Redwood City, CA, United States, 94063
Industry	Health Technology
CEO	Dr. Laurent Fischer M.D.
E-voting on shares	Click here to vote

Key Management of Adverum Biotechnologies Inc

Name	Title
Ms. Linda M. Rubinstein M.A.	CFO, Principal Financial Officer & Principal Accounting Officer
Mr. Kishor Peter Soparkar J.D.	Chief Operating Officer
Dr. R. Andrew Ramelmeier Ph.D.	Chief Technology Officer
Dr. Romuald Corbau Ph.D.	Chief Scientific Officer
Ms. Aneta Ferguson	General Counsel
Ms. Dena House	Chief People Officer
Dr. Laurent Fischer M.D.	President, CEO & Director
Dr. Setareh Seyedkazemi Pharm.D.	Chief Development Officer
Dr. Rabia Gurses Ozden M.D.	Chief Medical Officer
Ms. Carla Fiankan	Senior Vice President of Regulatory Affairs

FAQs

What is Adverum Biotechnologies Inc share price today?

Adverum Biotechnologies Inc share price today is $3.06 as on September 16, 2025 at 1:29 am IST at the close of the market. Adverum Biotechnologies Inc share today touched a day high of $3.23 and a low of $3.04.

What is the 52 week high and 52 week low for Adverum Biotechnologies Inc share?

Adverum Biotechnologies Inc share touched a 52 week high of $8.56 on October 18, 2024 and a 52 week low of $1.78 on May 15, 2025. Adverum Biotechnologies Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $3.06,which is 64.25% down from its 52 week high and 71.91% up from its 52 week low.

What is Adverum Biotechnologies Inc's market capitalisation today?

Adverum Biotechnologies Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Adverum Biotechnologies Inc Stock (ADVM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Adverum Biotechnologies Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adverum Biotechnologies Inc Shares that will get you 0.4902 shares as per Adverum Biotechnologies Inc share price of $3.06 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Adverum Biotechnologies Inc Stock (ADVM) from India?

Indian investors can start investing in Adverum Biotechnologies Inc (ADVM) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 1:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Adverum Biotechnologies Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 1:37 am IST). Based on Adverum Biotechnologies Inc share’s latest price of $3.06 as on September 16, 2025 at 1:29 am IST, you will get 3.2680 shares of Adverum Biotechnologies Inc. Learn more about fractional shares .

What are the returns that Adverum Biotechnologies Inc has given to Indian investors in the last 5 years?

Adverum Biotechnologies Inc stock has given -97.65% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?